| [1] |
Kessler RC. The costs of depression[J]. Psychiatr Clin North Am, 2012, 35(1): 1-14.
|
| [2] |
Druss BG, Hwang I, Petukhova M, et al. Impairment in role functioning in mental and chronic medical disorders in the United States: results from the National Comorbidity Survey Replication[J]. Mol Psychiatry, 2009, 14(7): 728-737.
|
| [3] |
WHO Guidelines Approved by the Guidelines Review Committee. mhGAP: mental health gap action programme: scaling up care for mental, neurological and substance use disorders[M]. Geneva: World Health Organization, 2008.
|
| [4] |
Soczynska JK, Mansur RB, Brietzke E, et al. Novel therapeutic targets in depression: Minocycline as a candidate treatment[J]. Behav Brain Res, 2012, 235(2): 302-317.
|
| [5] |
Narang P, Retzlaff A, Brar K, et al. Deep brain stimulation for treatment-refractory depression[J]. South Med J, 2016, 109(11): 700-703.
|
| [6] |
Anderson HD, Pace WD, Libby AM, et al. Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study[J]. Clin Ther, 2012, 34(1): 113-123.
|
| [7] |
Eyles DW, Burne TH, McGrath JJ. Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease[J]. Front Neuroendocrinol, 2013, 34(1): 47-64.
|
| [8] |
Holick MF. Vitamin D deficiency[J]. N Engl J Med, 2007, 375(3): 266-281.
|
| [9] |
Holick MF, Maclaughlin JA, Clark MB, et al. Photosynthesis of previtamin D3 in human skin and the physiologic consequences[J]. Science, 1980, 210(4466): 203-205.
|
| [10] |
Kongsbak M, Levring TB, Geisler C, et al. The vitamin D receptor and T cell function[J]. Front Immunol, 2013, 4: 148.
|
| [11] |
Hendrix I, Anderson P, May B, et al. Regulation of gene expression by the CYP27B1 promoter-study of a transgenic mouse model[J]. J Steroid Biochem Mol Biol, 2004, 89-90(1-5): 139-142.
|
| [12] |
Puchacz E, Stumpf WE, Stachowiak EK, et al. Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells[J]. Brain Res Mol Brain Res, 1996, 36(1): 193-196.
|
| [13] |
Newell KA, Matosin N. Rethinking metabotropic glutamate receptor 5 pathological findings in psychiatric disorders: implications for the future of novel therapeutics[J]. BMC Psychiatry, 2014, 14: 23.
|
| [14] |
Berridge MJ. Vitamin D and depression: cellular and regulatory mechanisms[J]. Pharmacol Rev, 2017, 69(2): 80-92.
|
| [15] |
Wohleb ES, Gerhard D, Thomas A, et al. Molecular and cellular mechanisms of rapid-acting antidepressants ketamine and scopolamine[J]. Curr Neuropharmacol, 2017, 15(1): 11-20.
|
| [16] |
Wyskiel DR, Andrade R. Serotonin excites hippocampal CA1 GABAergic interneurons at the stratum radiatum-stratum lacunosum moleculare border[J]. Hippocampus, 2016, 26(9): 1107-1114.
|
| [17] |
Schlecker C, Boehmerle W, Jeromin A, et al. Neuronal calcium sensor-1 enhancement of InsP3 receptor activity is inhibited by therapeutic levels of lithium[J]. J Clin Invest, 2006, 116(6): 1668-1674.
|
| [18] |
Soeiro-de-Souza MG, Salvadore G, Moreno RA, et al. Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder[J]. Neuropsychopharmacology, 2013, 38(3): 468-475.
|
| [19] |
Friedman AK, Juarez B, Ku SM, et al. KCNQ channel openers reverse depressive symptoms via an active resilience mechanism[J]. Nat Commun, 2016, 7: 11671.
|
| [20] |
Wasserman RH. Vitamin D and the dual processes of intestinal calcium absorption[J]. J Nutr, 2004, 134(11): 3137-3139.
|
| [21] |
Brewer LD, Thibault V, Chen KC, et al. Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons[J]. J Neurosci, 2001, 21(1): 98-108.
|
| [22] |
Gezen-Ak D, Dursun E, Yilmazer S. The effects of vitamin D receptor silencing on the expression of LVSCC-A1C and LVSCC-A1D and the release of NGF in cortical neurons[J]. PLoS One, 2011, 6(3): e17553.
|
| [23] |
Zhang C, Wu Z, Zhao G, et al. Identification of IL6 as a susceptibility gene for major depressive disorder[J]. Sci Rep, 2016, 6: 31264.
|
| [24] |
Xia L, Zhang D, Wang C, et al. PC-PLC is involved in osteoclastogenesis induced by TNF-α through upregulating IP3R1 expression[J]. FEBS Lett, 2012, 586(19): 3341-3348.
|
| [25] |
Dean B, Gibbons AS, Tawadros N, et al. Different changes in cortical tumor necrosis factor-α-related pathways in schizophrenia and mood disorders[J]. Mol Psychiatry, 2013, 18(7): 767-773.
|
| [26] |
Wei R, Christakos S. Mechanisms underlying the regulation of innate and adaptive immunity by vitamin D[J]. Nutrients, 2015, 7(10): 8251-8260.
|
| [27] |
Barbosa IG, Machado-Vieira R, Soares JC, et al. The immunology of bipolar disorder[J]. Neuroimmunomodulation, 2014, 21(2-3): 117-122.
|
| [28] |
Bánsághi S, Golenár T, Madesh M, et al. Isoform- and species-specific control of inositol 1,4,5-trisphosphate (IP3) receptors by reactive oxygen species[J]. J Biol Chem, 2014, 289(12): 8170-8181.
|
| [29] |
Lock JT, Sinkins WG, Schilling WP. Effect of protein S-glutathionylation on Ca2+ homeostasis in cultured aortic endothelial cells[J]. Am J Physiol Heart Circ Physiol, 2011, 300(2): H493-506.
|
| [30] |
Berk M, Williams LJ, Jacka FN, et al. So depression is an inflammatory disease, but where does the inflammation come from?[J]. BMC Med, 2013, 11: 200.
|
| [31] |
Consiglio M, Viano M, Casarin S, et al. Mitochondrial and lipogenic effects of vitamin D on differentiating and proliferating human keratinocytes[J]. Exp Dermatol, 2015, 24(10): 748-753.
|
| [32] |
Silvagno F, De Vivo E, Attanasio A, et al. Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytes[J]. PLoS One, 2010, 5(1): e8670.
|
| [33] |
Ryan ZC, Craig TA, Folmes CD, et al. 1α,25-dihydroxyvitamin D3 regulates mitochondrial oxygen consumption and dynamics in human skeletal muscle cells[J]. J Biol Chem, 2016, 291(3): 1514-1528.
|
| [34] |
Catena-Dell’Osso M, Bellantuono C, Consoli G, et al. Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development?[J]. Curr Med Chem, 2011, 18(2): 245-255.
|
| [35] |
Thompson SM, Kallarackal AJ, Kvarta MD, et al. An excitatory synapse hypothesis of depression[J]. Trends Neurosci, 2015, 38(5): 279-294.
|
| [36] |
Chabas JF, Alluin O, Rao G, et al. Vitamin D2 potentiates axon regeneration[J]. J Neurotrauma, 2008, 25(10): 1247-1256.
|
| [37] |
Grecksch G, Rüthrich H, Höllt V, et al. Transient prenatal vitamin D deficiency is associated with changes of synaptic plasticity in the dentate gyrus in adult rats[J]. Psychoneuroendocrinology, 2009, 34(Suppl 1): S258-264.
|
| [38] |
Gezenak D, Dursun E, Yilmazer S. The effect of vitamin D treatment on nerve growth factor (NGF) release from hippocampal neurons[J]. Noro Psikiyatri Arsivi, 2014, 51(2): 157-162.
|
| [39] |
Björkhem-Bergman L, Bergman P. Vitamin D and patients with palliative cancer[J]. BMJ Support Palliat Care, 2016, 6(3): 287-291.
|
| [40] |
Jääskeläinen T, Knekt P, Suvisaari J, et al. Higher serum 25-hydroxyvitamin D concentrations are related to a reduced risk of depression[J]. Br J Nutr, 2015, 113(9): 1418-1426.
|
| [41] |
de Koning EJ, van Schoor NM, Penninx BW, et al. Vitamin D supplementation to prevent depression and poor physical function in older adults: study protocol of the D-Vitaal study, a randomized placebo-controlled clinical trial[J]. BMC Geriatr, 2015, 15: 151.
|
| [42] |
Gowda U, Mutowo MP, Smith BJ, et al. Vitamin D supplementation to reduce depression in adults: Meta-analysis of randomized controlled trials[J]. Nutrition, 2015, 31(3): 421-429.
|
| [43] |
Bahrami A, Mazloum SR, Maghsoudi S, et al. High Dose vitamin D supplementation is associated with a reduction in depression score among adolescent girls: a nine-week follow-up study[J]. J Diet Suppl, 2018, 15(2): 173-182.
|
| [44] |
Shaffer JA, Edmondson D, Wasson LT, et al. Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials[J]. Psychosom Med, 2014, 76(3): 190-196.
|
| [45] |
Li G, Mbuagbaw L, Samaan Z, et al. Efficacy of vitamin D supplementation in depression in adults: a systematic review[J]. J Clin Endocrinol Metab, 2014, 99(3): 757-767.
|